KELLI CORKERN: Open Payments
NPI 1629353990 · GONZALES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$574 in 32 payments from 12 companies in 2025. Trend: 2023 $636 · 2024 $496 · 2025 $574
Food & beverage: $574
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $77 |
| Axsome Therapeutics, Inc. | 3 | $74 |
| Novo Nordisk Inc | 4 | $66 |
| Phathom Pharmaceuticals, Inc. | 5 | $64 |
| Exact Sciences Corporation | 4 | $63 |
| Lundbeck LLC | 3 | $60 |
| Lilly USA, LLC | 3 | $57 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $35 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $24 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
Products named: Auvelity, VOQUEZNA, REXULTI, Ozempic, The Cologuard Plus Collection Kit, UBRELVY, MOUNJARO, CAPLYTA.
Industry payments across LA — which companies pay providers there.
